NDTV Profit - Latest Suven Life Sciences Surges On Announcing Phase 3 Trial For Alzheimer's Drug By चन्द्र कुमार अधिकारी Tuesday, August 17, 2021 Comment Shares of drug maker Suven Life Sciences rose as much as 10.65 per cent to hit an intraday high of Rs 87.80. from NDTV Profit - Latest https://ift.tt/3g9bBuJ Related PostsCentre Hikes Sugar FRP Price To Rs 290 Per QuintalCentrum Capital Gains Over 3% After Board Approves Transfer Of SubsidiariesSensex, Nifty End On Flat Note; Reliance Industries, TCS Top Gainers''Monetisation Plan To Enhance Capex, Revive Credit Flow'': Amitabh Kant
0 Response to "Suven Life Sciences Surges On Announcing Phase 3 Trial For Alzheimer's Drug"
Post a Comment